Expanding access to investigational therapies for HIV infection and AIDS: March 12-13, 1990, conference summary
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C.
National Academy Press
1991
|
| Schlagworte: | |
| Beschreibung: | Includes bibliographical references |
| Beschreibung: | viii, 73 p |
| ISBN: | 0309044901 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044106699 | ||
| 003 | DE-604 | ||
| 005 | 20191106 | ||
| 006 | a |||| 10||| | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 170217s1991 |||| o||u| ||||||eng d | ||
| 020 | |a 0309044901 |9 0-309-04490-1 | ||
| 035 | |a (ZDB-30-PAD)EBC3375988 | ||
| 035 | |a (ZDB-89-EBL)EBL3375988 | ||
| 035 | |a (OCoLC)559734779 | ||
| 035 | |a (DE-599)BVBBV044106699 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 362.1/969792/00973 |2 20 | |
| 084 | |a MS 6280 |0 (DE-625)123748: |2 rvk | ||
| 100 | 1 | |a Nichols, Eve K. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Expanding access to investigational therapies for HIV infection and AIDS |b March 12-13, 1990, conference summary |c Eve Nichols [writer] ; Roundtable for the Development of Drugs and Vaccines against AIDS, Institute of Medicine |
| 264 | 1 | |a Washington, D.C. |b National Academy Press |c 1991 | |
| 300 | |a viii, 73 p | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references | ||
| 650 | 4 | |a Gesellschaft | |
| 650 | 4 | |a AIDS (Disease) |x Chemotherapy |x Social aspects |z United States |v Congresses | |
| 650 | 4 | |a Pharmacology, Experimental |x Social aspects |z United States |v Congresses | |
| 650 | 4 | |a HIV infections |x Chemotherapy |x Social aspects |z United States |v Congresses | |
| 650 | 0 | 7 | |a Viruzid |0 (DE-588)4139555-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Aids |0 (DE-588)4112470-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a HIV-Infektion |0 (DE-588)4203852-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Impfstoff |0 (DE-588)4026655-2 |2 gnd |9 rswk-swf |
| 651 | 4 | |a USA | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a HIV-Infektion |0 (DE-588)4203852-2 |D s |
| 689 | 0 | 1 | |a Impfstoff |0 (DE-588)4026655-2 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 689 | 1 | 0 | |a Aids |0 (DE-588)4112470-4 |D s |
| 689 | 1 | 1 | |a Viruzid |0 (DE-588)4139555-4 |D s |
| 689 | 1 | |8 2\p |5 DE-604 | |
| 912 | |a ZDB-30-PAD | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029513544 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Datensatz im Suchindex
| _version_ | 1804177171749535744 |
|---|---|
| any_adam_object | |
| author | Nichols, Eve K. |
| author_facet | Nichols, Eve K. |
| author_role | aut |
| author_sort | Nichols, Eve K. |
| author_variant | e k n ek ekn |
| building | Verbundindex |
| bvnumber | BV044106699 |
| classification_rvk | MS 6280 |
| collection | ZDB-30-PAD |
| ctrlnum | (ZDB-30-PAD)EBC3375988 (ZDB-89-EBL)EBL3375988 (OCoLC)559734779 (DE-599)BVBBV044106699 |
| dewey-full | 362.1/969792/00973 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 362 - Social problems and services to groups |
| dewey-raw | 362.1/969792/00973 |
| dewey-search | 362.1/969792/00973 |
| dewey-sort | 3362.1 6969792 3973 |
| dewey-tens | 360 - Social problems and services; associations |
| discipline | Soziologie |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02173nmm a2200541zc 4500</leader><controlfield tag="001">BV044106699</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20191106 </controlfield><controlfield tag="006">a |||| 10||| </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170217s1991 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309044901</subfield><subfield code="9">0-309-04490-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-30-PAD)EBC3375988</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-89-EBL)EBL3375988</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)559734779</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044106699</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">362.1/969792/00973</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MS 6280</subfield><subfield code="0">(DE-625)123748:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Nichols, Eve K.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Expanding access to investigational therapies for HIV infection and AIDS</subfield><subfield code="b">March 12-13, 1990, conference summary</subfield><subfield code="c">Eve Nichols [writer] ; Roundtable for the Development of Drugs and Vaccines against AIDS, Institute of Medicine</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">National Academy Press</subfield><subfield code="c">1991</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">viii, 73 p</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gesellschaft</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">AIDS (Disease)</subfield><subfield code="x">Chemotherapy</subfield><subfield code="x">Social aspects</subfield><subfield code="z">United States</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology, Experimental</subfield><subfield code="x">Social aspects</subfield><subfield code="z">United States</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">HIV infections</subfield><subfield code="x">Chemotherapy</subfield><subfield code="x">Social aspects</subfield><subfield code="z">United States</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Viruzid</subfield><subfield code="0">(DE-588)4139555-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Aids</subfield><subfield code="0">(DE-588)4112470-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">HIV-Infektion</subfield><subfield code="0">(DE-588)4203852-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">HIV-Infektion</subfield><subfield code="0">(DE-588)4203852-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Impfstoff</subfield><subfield code="0">(DE-588)4026655-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Aids</subfield><subfield code="0">(DE-588)4112470-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Viruzid</subfield><subfield code="0">(DE-588)4139555-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-30-PAD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029513544</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV044106699 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:43:50Z |
| institution | BVB |
| isbn | 0309044901 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029513544 |
| oclc_num | 559734779 |
| open_access_boolean | |
| physical | viii, 73 p |
| psigel | ZDB-30-PAD |
| publishDate | 1991 |
| publishDateSearch | 1991 |
| publishDateSort | 1991 |
| publisher | National Academy Press |
| record_format | marc |
| spelling | Nichols, Eve K. Verfasser aut Expanding access to investigational therapies for HIV infection and AIDS March 12-13, 1990, conference summary Eve Nichols [writer] ; Roundtable for the Development of Drugs and Vaccines against AIDS, Institute of Medicine Washington, D.C. National Academy Press 1991 viii, 73 p txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references Gesellschaft AIDS (Disease) Chemotherapy Social aspects United States Congresses Pharmacology, Experimental Social aspects United States Congresses HIV infections Chemotherapy Social aspects United States Congresses Viruzid (DE-588)4139555-4 gnd rswk-swf Aids (DE-588)4112470-4 gnd rswk-swf HIV-Infektion (DE-588)4203852-2 gnd rswk-swf Impfstoff (DE-588)4026655-2 gnd rswk-swf USA (DE-588)1071861417 Konferenzschrift gnd-content HIV-Infektion (DE-588)4203852-2 s Impfstoff (DE-588)4026655-2 s 1\p DE-604 Aids (DE-588)4112470-4 s Viruzid (DE-588)4139555-4 s 2\p DE-604 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Nichols, Eve K. Expanding access to investigational therapies for HIV infection and AIDS March 12-13, 1990, conference summary Gesellschaft AIDS (Disease) Chemotherapy Social aspects United States Congresses Pharmacology, Experimental Social aspects United States Congresses HIV infections Chemotherapy Social aspects United States Congresses Viruzid (DE-588)4139555-4 gnd Aids (DE-588)4112470-4 gnd HIV-Infektion (DE-588)4203852-2 gnd Impfstoff (DE-588)4026655-2 gnd |
| subject_GND | (DE-588)4139555-4 (DE-588)4112470-4 (DE-588)4203852-2 (DE-588)4026655-2 (DE-588)1071861417 |
| title | Expanding access to investigational therapies for HIV infection and AIDS March 12-13, 1990, conference summary |
| title_auth | Expanding access to investigational therapies for HIV infection and AIDS March 12-13, 1990, conference summary |
| title_exact_search | Expanding access to investigational therapies for HIV infection and AIDS March 12-13, 1990, conference summary |
| title_full | Expanding access to investigational therapies for HIV infection and AIDS March 12-13, 1990, conference summary Eve Nichols [writer] ; Roundtable for the Development of Drugs and Vaccines against AIDS, Institute of Medicine |
| title_fullStr | Expanding access to investigational therapies for HIV infection and AIDS March 12-13, 1990, conference summary Eve Nichols [writer] ; Roundtable for the Development of Drugs and Vaccines against AIDS, Institute of Medicine |
| title_full_unstemmed | Expanding access to investigational therapies for HIV infection and AIDS March 12-13, 1990, conference summary Eve Nichols [writer] ; Roundtable for the Development of Drugs and Vaccines against AIDS, Institute of Medicine |
| title_short | Expanding access to investigational therapies for HIV infection and AIDS |
| title_sort | expanding access to investigational therapies for hiv infection and aids march 12 13 1990 conference summary |
| title_sub | March 12-13, 1990, conference summary |
| topic | Gesellschaft AIDS (Disease) Chemotherapy Social aspects United States Congresses Pharmacology, Experimental Social aspects United States Congresses HIV infections Chemotherapy Social aspects United States Congresses Viruzid (DE-588)4139555-4 gnd Aids (DE-588)4112470-4 gnd HIV-Infektion (DE-588)4203852-2 gnd Impfstoff (DE-588)4026655-2 gnd |
| topic_facet | Gesellschaft AIDS (Disease) Chemotherapy Social aspects United States Congresses Pharmacology, Experimental Social aspects United States Congresses HIV infections Chemotherapy Social aspects United States Congresses Viruzid Aids HIV-Infektion Impfstoff USA Konferenzschrift |
| work_keys_str_mv | AT nicholsevek expandingaccesstoinvestigationaltherapiesforhivinfectionandaidsmarch12131990conferencesummary |